Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
AOTI, Inc. ( (GB:AOTI) ) just unveiled an announcement.
AOTI, Inc. announced that its Non-executive Chairman, Mr. Douglas Lefort, and his spouse transferred 361,453 common shares into their Self-Invested Personal Pensions (SIPPs) from their consulting vehicle, Wolfpack Consulting Limited. Despite these transactions, Mr. Lefort’s beneficial holding in the company remains unchanged at 1,451,621 shares, representing about 1.36% of the company’s issued share capital. This move is part of a routine financial strategy and does not alter the overall shareholding structure, maintaining stability for stakeholders.
More about AOTI, Inc.
AOTI, Inc., established in 2006, operates in the healthcare industry with a focus on providing innovative solutions for severe and chronic wounds. The company is known for its patented non-invasive Topical Wound Oxygen (TWO2®) therapy, which significantly reduces the recurrence of Diabetic Foot Ulcers and related hospitalizations and amputations. AOTI’s products have received regulatory approvals across multiple regions, including the US, Europe, UK, Canada, China, Australia, and Saudi Arabia.
YTD Price Performance: -14.41%
Average Trading Volume: 65,230
Technical Sentiment Signal: Strong Buy
Current Market Cap: £101M
For detailed information about AOTI stock, go to TipRanks’ Stock Analysis page.